I believe the answer is C but I’m not 100% sure
Answer:
The high energy electrons from chlorophyll to other molecules are transferred by this molecule.
Explanation:
NADP is an important molecule which is used in the production of energy in the form of ATP. During the process of photosynthesis it acts as a universal electron carrier. It accepts electrons and hydrogen atoms to form NADPH. NADPH then moves to the other location of reactions and there it donates the energy stored in bonds along with hydrogen and electrons to other molecules and again becomes NADP.
Answer:
Naloxone is an antagonist at opioid receptors and heroin is an agonist at opioid receptors
Explanation:
An agonist is a substance that binds to a receptor and causes a biological reaction. In this case, heroine binds to opioid receptors. An antagonist blocks the reaction from the agonist, impeding the receptor's activation. Agonists and antagonists work for specific receptors, and for an antagonist to block an agonist they must bind to the same receptor, like naloxone does with heroin. Giving an antagonist that binds to one receptor and and agonist that binds to a different one means that the antagonist will have no effect.
Answer:
True.
Explanation:
Enkephalins and endorphins are endogenous peptides while morphine is an exogenous peptide.
Enkephalins and endorphins are powerful analgesics 18 to 500 times more than morphine. Hence, morphine is less analgesic than enkephalins and endorphins.
Enkephalins and endorphins act on the mu, kappa , delta receptors and morphine also acts on the same receptors. All of them has same effects on the body.
Hence, Enkephalins and endorphins are peptides that act like morphine.
Answer:
A. Pharmacogenomics
Explanation:
The use of persons genetic makeup or information or genome, to select or choose the medicine and dosage of the drugs to be administered that will likely work t for that particular person is called Pharmacogenomics . This field of science combines the knowledge of how drugs work, called pharmacology, with the knowledge of the human genome, called genomics.
The aim of Pharmacogenomics is to optimize drug therapy, with consideration on the patients' genotype. Moreover it targets to ensure maximum efficiency with minimum adverse reactions. By utilizing pharmacogenomics, we have a high hope that drug treatments can veer away from the "one-dose-fits-all" approach to medication.